{"schema_version":"secwatch.filing_event.v1","accession":"0001360604-23-000020","form_type":"8-K","ticker":"HR","cik":"0001360604","company_name":"Healthcare Realty Trust Inc","filed_at":"2023-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.613893+00:00","generated_at":"2026-06-18T17:21:35.150838+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Healthcare Realty Trust Q4 net loss $35.8M; Normalized FFO $0.42 per share","bullets":["Net loss attributable to common stockholders of $35.8M ($0.09 diluted EPS) for Q4 2022.","Normalized FFO of $159.8M, or $0.42 per diluted share.","Same store cash NOI (incl. JV share) increased 2.8% YoY in Q4; TTM growth 2.6%.","Dividend of $0.31 per share payable March 21, 2023 to holders of record March 7.","Closed on $1.25B in JV and asset sales in 2022 at 4.8% cap rate; additional $112.8M sales post-year-end."],"urls":{"canonical":"https://secwatch.observer/filing/0001360604-23-000020","json":"https://secwatch.observer/filing/0001360604-23-000020.json","markdown":"https://secwatch.observer/filing/0001360604-23-000020.md","text":"https://secwatch.observer/filing/0001360604-23-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1360604/000136060423000020/0001360604-23-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1360604/000136060423000020/hr-20230301.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T17:21:35.150838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"07222afbedd246147cf5b0c0edd688107ab08a4d","claim":"Healthcare Realty Trust Inc reported the fourth quarter ended December 31, 2022 results: net income $35.8 million, EPS $0.09 per diluted common share.","evidence_excerpt":"The Company reported net loss attributable to common stockholders of $35.8 million, or $0.09 per diluted common share, for the quarter ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1360604/000136060423000020/0001360604-23-000020-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Net income","value":"$35.8 million"},{"label":"EPS","value":"$0.09 per diluted common share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}